Melanoma in mice: tryptophan degradation by intestinal Bacteroides limits tumor growth
According to a preclinical study in mice, the degradation of tryptophan into indoles by the TnaA enzyme found in Bacteroides uniformis appears to contribute to a reduction in melanoma size, a type of skin cancer. In humans, patients who respond to immunotherapy (a treatment that stimulates the immune system to fight tumor cells) show a similar trend, although this finding remains to be confirmed.1
Lay public section
Find here your dedicated sectionSources
This article is based on scientific information
About this article
A mouse raised in a sterile environment, devoid of any microbiome. Following colonization with a selected bacterial species, this model makes it possible to isolate the effects of that species without interference from other microorganisms.
Therapeutic antibodies that target immune system “brakes,” such as CTLA-4 or the PD-1 pathway, to restore the function of anti-tumor T cells.2 CTLA-4 and PD-1 are proteins expressed on the surface of immune cells. Certain tumor cells express PD-L1 on their surface, which binds to PD-1 and activates this “brake”, allowing them to evade the immune response. Anti-PD-1 or anti-PD-L1 antibodies block this interaction.
A U.S. public program dedicated to the molecular characterization of tumors (including genomic, epigenomic, transcriptomic, and proteomic analyses) across 33 cancer types. The data are publicly available to researchers.3
Immune cells capable of recognizing and destroying antigens on the surface of tumor cells; they play a key role in anti-tumor immunity.
Immune cells that present antigens—such as those captured from a tumor—to T cells, thereby triggering an immune response.
A molecule recognized by the immune system. Tumor antigens, present on the surface of cancer cells, enable T cells to recognize the tumor.
Two Bacteroides species inhibit melanoma growth in mice
In this preclinical study published in Cell Reports Medicine,1 two closely related species, both phenotypically and genetically–Bacteroides rodentium (a murine species) and B. uniformis (a species found in humans)–limit melanoma growth. This anti-tumor effect was observed in several murine models: mice that were initially germ-free (lacking a microbiota) and subsequently colonized with a controlled and defined microbiota; mice with a complex microbiota; and conventional mice.
In the presence of B. rodentium, tumors contain more CD8+ T cells—also known as cytotoxic T cells because they can destroy tumor cells—and express higher levels of immune-activating genes. In the presence of B. uniformis, the proportion of several CD8+ and CD4+ T cell subpopulations expressing activation markers also increases in the tumor. These T cells play a key role in the the anti-tumor immune response, becoming activated when dendritic cells present them with specific tumor-derived antigens. These results suggest that both of these bacteria promote anti-tumor immunity in mice.
What the mouse experiments show
Models :
- Germ-free mice
- Mice with complex microbiota
- Conventional mice
Effect on melanoma size : Decrease.
Models : Germ-free mice.
Effect on melanoma size : No decrease.
Models : Conventional mice.
Effect on melanoma size : Decrease.
From tryptophan to indoles: the role of TnaA
Metabolomic analysis revealed lower tryptophan levels in the cecum of mice colonized by B. rodentium compared with control mice. In silico analysis of B. rodentium and B. uniformis genomes identified two enzymes capable of breaking down this amino acid into indoles: tryptophanase A (TnaA), which produces indole, a precursor of indoxyl sulfate; and aromatic aminotransferase (ArAT), which produces indole-3-pyruvate, itself a precursor of indole-3-lactate. In germ-free mice, deletion of the TnaA gene in B. uniformis significantly reduces indole production. At the same time, melanoma size no longer decreases. These findings suggest that the degradation of tryptophan into indole contributes to the anti-tumor effect. The scientists then directly tested four different indole metabolites, administering them to conventional mice by daily gavage (40 mg/kg). This treatment resulted in a reduction in melanoma size, accompanied by greater infiltration of the tumors by cytotoxic CD8+ T cells and other immune cells, including CD11c+ cells (associated with dendritic cells) and F4/80+ cells (a macrophage marker). The mechanism through which indoles influence the immune response at the cellular level remains to be elucidated. These findings suggest that indoles, which are degradation products of tryptophan, can inhibit tumor growth in mice, an effect associated with an enhanced anti-tumor immune response. The authors suggest that a better understanding of how the gut microbiota regulates anti-tumor immunity could open up new therapeutic avenues.
From bacteria to indoles
Products : Indole, indoxyl sulfate.
Effect of indole administration on melanoma size in mice : Decrease.
Products : Indole-3-pyruvate, indole-3-lactate.
Effect of indole administration on melanoma size in mice : Decrease.
A trend that remains to be confirmed in humans
In humans, a reanalysis of previously published data on the fecal microbiota of patients with various types of cancer, including melanoma, using samples collected before treatment with immune checkpoint inhibitors2 (antibodies that release certain “brakes” on the immune system), suggests a similar trend. In one of the cohorts, ArAT gene expression was higher in patients who responded favorably to treatment. For TnaA, which was analyzed across four cohorts, the same trend was observed in two of them, although the differences were not statistically significant.
In the public TCGA (The Cancer Genome Atlas) database, which includes data on solid tumors, the presence of Bacteroides spp. is associated with better overall survival.3 These observational data in humans demonstrate associations only; they do not establish a direct role for these bacteria in cancer progression. Nevertheless, these findings suggest that future studies should investigate whether administration of ArAT or TnaA, either individually or in combination, could induce anti-tumor immunity and improve patients' responses to oncological treatments.
What the human data show
Analyzed data : One cohort of melanoma patients.
Result : Higher in patients who responded to treatment.
Analyzed data : Four cohorts of melanoma patients.
Result : No significant difference; a trend toward higher abundance in responders was observed in two cohorts.
Analyzed data : TCGA public database containing genetic and survival data of patients with solid tumors.
Result : Associated with better overall survival.
Declaration of interests
The authors declare that a provisional patent application has been filed covering the findings of this study.
1. Diaz Olea, X., Beede, K., Pereira, G., Scott, D., Petucci, C., Martens, E., Rodionov, D., Shah, A., Martinez, M.P., Kim, H., Sharma, A.K., Martin, A., Zhang, T., Faries, M.B., Hamid, O., Devkota, S., Osterman, A., Knott, S., Voest, E.E., Ajami, N.J., Wargo, J., Ramer-Tait, A.E. & Ronai, Z.A. (2026). Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth. Cell Reports Medicine, 7(7), 102921. https://doi.org/10.1016/j.xcrm.2026.102921
2. Ribas, A. & Wolchok, J.D. (2018). Cancer immunotherapy using checkpoint blockade. Science, 359(6382), 1350-1355. https://doi.org/10.1126/science.aar4060
3. National Cancer Institute. The Cancer Genome Atlas Program (TCGA).
https://www.cancer.gov/ccg/research/genome-sequencing/tcga (consulté le 23 octobre 2026)
See also